Oracle Names Stephen Rusckowski to the Board of Directors

Rhea-AI Summary

Oracle (NYSE: ORCL) unanimously elected Stephen Rusckowski to its Board of Directors, increasing the Board size to 14. The election is effective as of November 18, 2025.

Rusckowski is the former CEO and President of Quest Diagnostics from 2012–2022 and served as Quest Board Chair from January 2017–March 2023. He previously led Philips Healthcare and currently serves on the supervisory board of Qiagen N.V. and as a director of Baxter International. Board members serve one-year terms and will next stand for election at the annual meeting in November 2026.

Positive

• Board size increased to 14, adding governance flexibility
• Healthcare and tech expertise from Rusckowski to inform Oracle Health
• Senior leadership experience: CEO of Quest Diagnostics 2012–2022
• Public board experience at Qiagen and Baxter enhances oversight

Negative

• None.

News Market Reaction

-6.58%

51 alerts

-6.58% News Effect

-4.1% Trough in 1 hr 27 min

-$40.54B Valuation Impact

$575.53B Market Cap

0.9x Rel. Volume

On the day this news was published, ORCL declined 6.58%, reflecting a notable negative market reaction. Argus tracked a trough of -4.1% from its starting point during tracking. Our momentum scanner triggered 51 alerts that day, indicating high trading interest and price volatility. This price movement removed approximately $40.54B from the company's valuation, bringing the market cap to $575.53B at that time.

Data tracked by StockTitan Argus on the day of publication.

AUSTIN, Texas, Nov. 20, 2025 /PRNewswire/ -- Oracle Corporation (NYSE: ORCL) today announced that it unanimously elected Stephen Rusckowski to Oracle's Board of Directors and increased the size of the Board to 14. The election is effective as of November 18, 2025.

Mr. Rusckowski is the former Chief Executive Officer and President of Quest Diagnostics, Inc. (Quest), a leading provider of diagnostic information, a position he held from 2012 until 2022. He also served as Chair of the Board of Quest from January 2017 through March 2023. Prior to joining Quest, he served as the Chief Executive Officer of Philips Healthcare, and a member of the Board of Management of Royal Philips Electronics. Mr. Rusckowski currently serves on the supervisory board of Qiagen N.V. and as a director of Baxter International Inc. Mr. Rusckowski earned a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute and a Master of Science degree in Management from the Massachusetts Institute of Technology's Sloan School of Management.

"Steve's years of experience in healthcare and technology will enable him to provide the Oracle Board with a unique perspective as to how Oracle Health can better serve patients and healthcare providers around the world," said Larry Ellison, Oracle's Board Chairman and Chief Technology Officer.

Bruce Chizen, Chair of the Nomination and Governance Committee, added, "I am pleased to welcome Steve to the Board. We believe that Oracle, along with its customers and shareholders, will benefit from his extensive experience in leading and advising global healthcare organizations."

Members of Oracle's Board of Directors serve one-year terms and will next stand for election at the company's annual meeting of stockholders in November 2026.

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

"Safe Harbor" Statement:  Statements in this press release relating to Oracle's future plans, expectations, beliefs, intentions, and prospects are "forward-looking statements" and are subject to material risks and uncertainties. A detailed discussion of these factors and other risks that affect our business is contained in Oracle's Securities and Exchange Commission (SEC) filings, including our most recent reports on Form 10-K and Form 10-Q under the heading "Risk Factors." These filings are available on the SEC's website or on Oracle's website at http://www.oracle.com/investor. All information in this press release is current as of November 20, 2025, and Oracle undertakes no duty to update any statement in light of new information or future events.

View original content:https://www.prnewswire.com/news-releases/oracle-names-stephen-rusckowski-to-the-board-of-directors-302622591.html

SOURCE Oracle

FAQ

When was Stephen Rusckowski elected to Oracle's board (ORCL)?

Stephen Rusckowski's election to Oracle's board is effective as of November 18, 2025.

How many directors will Oracle (ORCL) have after the November 2025 board change?

Oracle's Board size was increased to 14 directors.

What relevant experience does Stephen Rusckowski bring to Oracle (ORCL)?

He served as CEO and President of Quest Diagnostics from 2012–2022, was Quest Board Chair Jan 2017–Mar 2023, led Philips Healthcare, and serves on boards of Qiagen and Baxter.

When will Oracle (ORCL) directors next stand for election?

Oracle's directors serve one-year terms and will next stand for election at the annual meeting in November 2026.

Will Stephen Rusckowski's appointment affect Oracle Health initiatives (ORCL)?

Oracle said his healthcare and technology background will provide a perspective to help Oracle Health better serve patients and providers.

Who announced Stephen Rusckowski's appointment to Oracle (ORCL) board?

Oracle announced the unanimous election and included comments from Board Chairman Larry Ellison and Nomination Committee Chair Bruce Chizen.